Polaryx Therapeutics, Inc (PLYX) Price Prediction & ForecastPLYXPolaryx Therapeutics, Inc

Alphio's PLYX stock price prediction model matches the current Polaryx Therapeutics, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.74 (+0.09%). The 1-week path is $1.72 (-0.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Polaryx Therapeutics (PLYX) is trading at $1.75, significantly below the analyst price targets of $6 and $7, indicating potential upside. However, the stock has seen a year-to-date decline of 80.18%, which raises concerns about its stability. The RSI is at 23.403, suggesting that the stock is oversold, but the negative net income trend, with losses of $2,544,000 in Q1 2026, presents a risk. Therefore, while there is potential for recovery, the current financial performance and market sentiment suggest holding rather than buying at this time.

Polaryx Therapeutics, Inc (PLYX) last closed at $1.74, losing -3.33%. These facts feed the 1-day and 1-week PLYX price prediction above.